In gastric cancer, S256-phosphorylated FOXO1 correlates with higher overall survival and lower tumor angiogenesis, suggesting that activated FOXO1 supports tumor growth and metastasis (14, 15). The gene discussed is FOXO1; the disease is neoplasm.